Bradley Louis Radoff, Director at ENZO BIOCHEM INC (ENZ), bought 12,500 shares at $2.27 ($28K) on 2022-07-12, disclosed to the SEC on 2022-07-13.
Open-market purchase of $28k ENZ by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| KVHI | SELL | 2026-05-29 | $392K | — | Filing → |
| KVHI | BUY | 2026-02-12 | $188K | — | Filing → |
| HHS | BUY | 2024-12-06 | $100K | — | Filing → |